Syndax Pharmaceuticals Inc·4

Dec 1, 4:30 PM ET

Goldan Keith A. 4

4 · Syndax Pharmaceuticals Inc · Filed Dec 1, 2025

Insider Transaction Report

Form 4
Period: 2025-12-01
Goldan Keith A.
Chief Financial Officer
Transactions
  • Gift

    Common Stock

    2025-12-011,22492,452 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4